Zelefsky MJ - Search Results

1

Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancer.

Ryan CJ, Zelefsky MJ, Heller G, Regan K, Leibel SA, Scher HI, Kelly WK. Ryan CJ, et al. Among authors: zelefsky mj. Urology. 2004 Jul;64(1):90-4. doi: 10.1016/j.urology.2004.03.006. Urology. 2004. PMID: 15245942 Clinical Trial.

2

Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy.

Zelefsky MJ, Scher HI, Krol G, Portenoy RK, Leibel SA, Fuks ZY. Zelefsky MJ, et al. Cancer. 1992 Nov 1;70(9):2319-25. doi: 10.1002/1097-0142(19921101)70:9<2319::aid-cncr2820700918>3.0.co;2-8. Cancer. 1992. PMID: 1394060

3

Limited small cell lung cancer: prognostic significance of a complete response to the induction phase of chemotherapy followed by thoracic irradiation.

Armstrong JG, Rosenstein MM, Scher HI, Fass DE, Zelefsky MJ, Kris MG. Armstrong JG, et al. Among authors: zelefsky mj. Radiology. 1991 Mar;178(3):875-8. doi: 10.1148/radiology.178.3.1847240. Radiology. 1991. PMID: 1847240 Clinical Trial.

4

Palliative hemiskeletal irradiation for widespread metastatic prostate cancer: a comparison of single dose and fractionated regimens.

Zelefsky MJ, Scher HI, Forman JD, Linares LA, Curley T, Fuks Z. Zelefsky MJ, et al. Int J Radiat Oncol Biol Phys. 1989 Dec;17(6):1281-5. doi: 10.1016/0360-3016(89)90537-3. Int J Radiat Oncol Biol Phys. 1989. PMID: 2480941 Clinical Trial.

5

Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study.

Leibel SA, Heimann R, Kutcher GJ, Zelefsky MJ, Burman CM, Melian E, Orazem JP, Mohan R, LoSasso TJ, Lo YC, et al. Leibel SA, et al. Among authors: zelefsky mj. Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):55-65. doi: 10.1016/0360-3016(94)90141-4. Int J Radiat Oncol Biol Phys. 1994. PMID: 7505776 Clinical Trial.

6

Short-term freedom from disease progression after I-125 prostate implantation.

Wallner K, Roy J, Zelefsky M, Fuks Z, Harrison L. Wallner K, et al. Int J Radiat Oncol Biol Phys. 1994 Sep 30;30(2):405-9. doi: 10.1016/0360-3016(94)90021-3. Int J Radiat Oncol Biol Phys. 1994. PMID: 7523345

7

Significance of normal serum prostate-specific antigen in the follow-up period after definitive radiation therapy for prostatic cancer.

Zelefsky MJ, Leibel SA, Wallner KE, Whitmore WF Jr, Fuks Z. Zelefsky MJ, et al. J Clin Oncol. 1995 Feb;13(2):459-63. doi: 10.1200/JCO.1995.13.2.459. J Clin Oncol. 1995. PMID: 7531221

8

Refining the predictive power of the prostate-specific antigen.

Zelefsky MJ, Fuks Z, Leibel SA. Zelefsky MJ, et al. Int J Radiat Oncol Biol Phys. 1993 Sep 1;27(1):171-2. doi: 10.1016/0360-3016(93)90435-x. Int J Radiat Oncol Biol Phys. 1993. PMID: 7690015 No abstract available.

9

Organ-function preservation in advanced oropharynx cancer: results with induction chemotherapy and radiation.

Pfister DG, Harrison LB, Strong EW, Shah JP, Spiro RW, Kraus DH, Armstrong JG, Zelefsky MJ, Fass DE, Weiss MH, et al. Pfister DG, et al. Among authors: zelefsky mj. J Clin Oncol. 1995 Mar;13(3):671-80. doi: 10.1200/JCO.1995.13.3.671. J Clin Oncol. 1995. PMID: 7884428 Clinical Trial.

10

Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study.

Leibel SA, Zelefsky MJ, Kutcher GJ, Burman CM, Kelson S, Fuks Z. Leibel SA, et al. Among authors: zelefsky mj. J Urol. 1994 Nov;152(5 Pt 2):1792-8. doi: 10.1016/s0022-5347(17)32387-x. J Urol. 1994. PMID: 7933238 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters